NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









NanoDx

NanoDx

Private
Southborough, MassachusettsHealthcare & Life Scienceshttps://nanodiagnostics.com/

Last Round

Series C

Jul 1, 2020

Total Funding Raised

$25.95M

Company Overview

NanoDx is a medical device company that develops point-of-care products for the objective diagnosis and management of concussions and other traumatic brain injuries.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Sensors

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Application

Keywords

point-of-care diagnosticsnanowire biosensorsPOC testingmedical devicein-vitro diagnosticsIVDdiagnostic analyzerbiomarker detectionrapid testingtraumatic brain injury diagnosticsTBI testingrazor-and-blade modelclinical diagnosticslab-on-a-chipbiosensor technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NanoDx Comparables

Compare NanoDx with similar companies based on industry and business-model similarity.

NanoDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nanopath
85%
BrainScope
83%
BRAINBox Solutions
78%

NanoDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJul 1, 2020
VC RoundApr 10, 2017
Series BFeb 3, 2016
Series AAug 19, 2013

Key People

Founding team and executive leadership

George J. Serafin

President CEO

Executive Team

NanoDx Investors

Notable investors and investment history

NanoDx investors
InvestorRounds
Paulson Investment CompanySeries A
Provident Healthcare CapitalVC Round, Series B
MedScience VenturesVC Round
Shepherd Kaplan KrochukSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 63% MoM.

  • Nov 13, 2025

    Monthly visitors grew 142% MoM, reaching 1.1K.

NanoDx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NanoDx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NanoDx's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouthborough, Massachusetts
Employee Range32
Year Founded2010
Last FundingJul 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.